Food and Drug Administration (FDA) advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry participants say consumer demand is likely to remain strong
Long-term safety data, including pancreatitis risk, gallbladder events, and any potential thyroid C-cell findings, will continue to accumulate through the Phase 3 TRIUMPH program
Da H, M zberk Ko, Dikker O, et al
Excellent consistency on shipments
Users who track closely may notice: Slight improvement in fasted cardio performance Marginally faster recovery from caloric restriction (less lethargy on deficit days) Possible 0.5-1lb scale change, though this is within normal fluctuation What to track: Daily weigh-ins and weekly measurements continue